Cesar Valdes MD

Dr. Cesar Rodriguez has practiced general Hematology and Oncology with a clinical focus on multiple myeloma in the US since 2006. After graduating from Instituto Tecnologico y de Estudios Superiores de Monterrey, Dr. Rodriguez practiced in Mexico for three years. He then moved to the US for his residency in Internal Medicine at Texas Tech University Health Sciences Center before completing his fellowship in Hematology and Oncology at the University of Louisville Hospital. With his board certifications in Internal Medicine and Medical Oncology, Dr. Rodriguez specializes in early development drugs and immunotherapy for multiple myeloma. Additionally, Dr. Rodriguez is multilingual and can communicate with patients in English, Spanish, and French.

In conjunction with his clinical role, Dr. Rodriguez serves as an Associate Professor of Hematology and Medical Oncology at the Icahn School of Medicine. He is also the Clinical Director of Multiple Myeloma at Mount Sinai Hospital and serves as a committee leader for immunotherapy in myeloma for the Clinical Trials Network Myeloma Intergroup. Dr. Rodriguez has also completed specialized training in cancer biology and therapeutics at Harvard Medical School and has expertise in early-phase clinical trials.